D Rai, A Ranjan, H Ameet, S Pandey - Cureus, 2021 - ncbi.nlm.nih.gov
Objective To assess clinical & laboratory parameters associated with adverse outcomes among 984 patients with COVID-19 infection admitted to a tertiary care hospital in eastern …
SK Sidhwani, T Mirza, A Khatoon, F Shaikh… - Journal of Infection and …, 2023 - Elsevier
Background The COVID-19 pandemic has resulted in a global humanitarian crisis. Despite ongoing research, transmission risks and many disease characteristics remained unclear …
Background C-reactive protein (CRP) is a non-specific acute phase reactant elevated in infection or inflammation. Higher levels indicate more severe infection and have been used …
T Pitre, A Jones, J Su, W Helmeczi, G Xu, C Lee… - Internal and emergency …, 2021 - Springer
Inflammatory biomarkers may be associated with disease severity and increased mortality in COVID-19 patients but have not been studied in North American populations. We sought to …
QQ Liu, A Cheng, Y Wang, H Li, L Hu, X Zhao… - BMJ open, 2020 - bmjopen.bmj.com
Objective To delineate the characteristics and clinical significance of plasma inflammatory cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …
HT Gozdas, SA Kayis, T Damarsoy… - Journal of Intensive …, 2022 - journals.sagepub.com
Aim Systemic inflammation has a crucial role in the pathogenesis and mortality of Coronavirus disease 2019 (COVID-19). Multi-inflammatory index (MII) is a novel index …
Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent need for identification of clinical and laboratory predictors for progression towards severe …
A Az, O Sogut, T Akdemir, H Ergenc… - … Journal of General …, 2021 - Taylor & Francis
Background We investigated potential predictive factors for mortality and disease severity from demographic and clinical data, comorbidities, and laboratory findings in patients with …
Abnormal inflammatory mediator concentrations during SARS-CoV-2 infection may represent disease severity. We aimed to assess plasma inflammatory mediator …